What is Monte Rosa Therapeutics, Inc.'s operating margin?

Monte Rosa Therapeutics, Inc. (GLUE) reported operating margin of -345.2% in Q1 2026.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Monte Rosa Therapeutics, Inc. GLUE Operating margin

Operating margin at other companies

Nurix Therapeutics, Inc.NRIX

-439.3%+35.3pp

Kymera TherapeuticsKYMR

-697.7%+635pp

ImmunomeIMNM

-5,947.9%-12,002pp

Adaptive BiotechnologiesADPT

-15.8%-7.0pp

Arcus BiosciencesRCUS

-168.6%-52.7pp

Nektar TherapeuticsNKTR

-242%—

Other financials

Income statement

See full

Revenue$4.2M-95.0%

Operating income-$50.0M-214%

Net income-$44.5M-195%

EPS (diluted)-$0.45-179%

Balance sheet

See full

Cash & equivalents$159.9M+104%

Total debt$39.1M-6.7%

Total equity$521.9M+89.7%

Total assets$736.4M+87.3%

Cash flow

See full

Operating cash flow-$37.4M+17.9%

CapEx$1.9M+17.7%

Free cash flow-$39.2M+16.7%

Valuation

See full

Market cap$1.75B+361%

Enterprise value$1.63B+381%

P/S40.7×+38.4×

Profitability

See full

Net margin-302.6%—

FCF margin-45.8%-64.9pp

Returns & leverage

See full

Return on equity-32.6%—

Debt / equity0.1×-0.1×

Current ratio9.5×+3.9×

Where this comes from

Calculated from Monte Rosa Therapeutics, Inc.’s reported figures.

operating income/total revenue=-345.2%

Based on trailing twelve months.

The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monte Rosa Therapeutics, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monte Rosa Therapeutics, Inc.'s operating margin?: Monte Rosa Therapeutics, Inc. (GLUE) reported operating margin of -345.2% in Q1 2026.
What does operating margin mean?: Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.